| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 14.36M | — |
| Operating expense | — | — |
| Net income | -19.50M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, ENTA returned +52.5% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -14.6% |
| 1 year | +52.5% |
| 5 years | -76.5% |
| 10 years | -38.7% |
| All-time high | $115.90 (Jun 2018) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in ENTA would be worth today ›No. Enanta Pharmaceuticals, Inc. has not paid a dividend in the past 12 months.
Enanta Pharmaceuticals, Inc. stock trades on NASDAQ under the ticker symbol ENTA.
Enanta Pharmaceuticals, Inc. is part of the Healthcare sector.
Enanta Pharmaceuticals, Inc. has a market cap of 392.32M USD, based on the latest quote.
Enanta Pharmaceuticals, Inc. is expected to report earnings around Nov 16, 2026. That date is an estimate and has not been confirmed by the company.
